Taiho Pharmaceutical confirms its performance on environmental targets, seeking to effectively reduce the environmental impact of its business activities. Here, as well as in our material balance and environmental accounting, which quantifies the environmental impact of our business activities and provides an overall picture of environmental impact, we list the changes in various environmental data by item.
Environmental Targets and Results
This table shows the results of various efforts to achieve targets. Going forward, we will continue to promote further initiatives to achieve the Otsuka Group's 2050 Environmental Vision of “Net Zero” of reducing all environmental impacts from business activities to zero.
|
Materiality |
2028 target | |
|---|---|---|
|
Carbon Neutrality |
Scope 1, 2: 50% reduction (compared to 2017) 20% self-generated renewable energy |
55.1% reduction Self-generated renewable energy utilization rate: 4.9% |
|
Circular Economy |
50% reduction in simple incineration and landfill disposal compared to 2019 |
39.9% reduction |
|
Water Neutrality |
Develop water management programs at all sites 10% reduction in water intake (compared with 2023) |
Water resource program survey Water intake: 4% increase |
Material Balance
The material balance represents the volume of resources and energies used in business activities (INPUT) and the products and environmental impacts generated by business activities (OUTPUT) together as a whole. Taiho Pharmaceutical is working to reduce these environmental impacts and to ensure proper management.
Water consumption: In fisical 2025, water consumption was 123,000 m3.
Water consumption refers to the amount of water that does not return to the water source again, such as by being taken in as part of an evaporation or product. This is an important index for assessing the impacts of water use on the water volume in the downstream areas and water shortages on the watershed, including aquatic ecosystems.
| Aggregation period | Actual data from January 1, 2025 to December 31, 2025 |
| Reporting boundary | Taiho Pharmaceutical Co., Ltd. and Okayama Taiho Pharmaceutical Co., Ltd. |
| Reference guidelines, etc. |
Environmental Reporting Guidelines, Ministry of the Environment, Japan PRTR Emissions Calculation Manual, Ministry of the Environment |
Environmental Accounting
Taiho Pharmaceuticals refers to the Environmental Accounting Guidelines 2005 edition of the Ministry of the Environment to calculate the amount of investments and expenses for preventing, reducing, or avoiding the occurrence of environmental loads, eliminating impacts, recovering the damage that has occurred, or contributing to these efforts.
|
Category |
FY2024 |
FY2025 | ||
|---|---|---|---|---|
|
Investment (million yen) |
Cost (million yen) |
Investment (million yen) |
Cost (million yen) | |
|
Pollution Prevention Cost |
5.0 |
59.8 |
14.2 |
139.9 |
|
Global Environmental Conservation Cost |
81.2 |
54.6 |
279.0 |
40.4 |
|
Resource Circulation Cost |
0.0 |
108.0 |
0.0 |
137.9 |
|
Upstream/Downstream Cost |
0.0 |
57.7 |
0.0 |
62.5 |
|
Administration Cost |
0.0 |
56.1 |
0.0 |
60.8 |
|
Social Activity Cost |
0.0 |
0.6 |
0.0 |
0.6 |
|
Environmental Remediation Cost |
- |
- |
- |
- |
|
Total |
86.2 |
336.7 |
293.2 |
442.1 |
